All Stories

  1. Mesalamine MMX for pediatric ulcerative colitis

    Article • Drug Design Development and Therapy, February 2016, Dove Medical Press

    Dr David Montague Pierce, Dr Bartosz Korczowski

  2. A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults

    Article • Drug Design Development and Therapy, February 2015, Taylor & Francis

    Dr David Montague Pierce

  3. Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials

    Article • Drug Design Development and Therapy, May 2014, Taylor & Francis

    Dr David Montague Pierce